REQUEST A DEMO
Total
USD $0.00
Search more companies

Srs Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Srs Pharmaceuticals Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Srs Pharmaceuticals Private Limited is an unlisted company, incorporated on 27/03/2001. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24239MH2001PTC131384 and registration number is 131384. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
504 Marathon Max Bldg No.2, Mulund-Goregoan Link, L.B.S Marg, Mulund West Mumbai Mh 400080 In
Mumbai; Maharashtra; Postal Code: 400080

Contact Details: Purchase the Srs Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Srs Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Srs Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Srs Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Srs Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
March 27, 2001
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Additional Executive Director
Ownership Details
Purchase this report to view the information.
99%
Subsidiaries
Adkure Technologies Private Limited
100%
Company Performance
Financial values in the chart are available after Srs Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.98%
Total operating revenue
-69.94%
Operating profit (EBIT)
-95.17%
EBITDA
-94.45%
Net Profit (Loss) for the Period
-95.3%
Total assets
6.7%
Total equity
4.37%
Operating Profit Margin (ROS)
-244.18%
Net Profit Margin
-191.47%
Return on Equity (ROE)
-68.63%
Debt to Equity Ratio
-1.2%
Quick Ratio
-0.65%
Cash Ratio
-0.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?